Samy Slimani

Summary

Affiliation: Faculty of Medicine

Publications

  1. doi request reprint Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate
    Samy Slimani
    Department of Rheumatology, Ben Aknoun Hospital, rue des Deux Bassins, Ben Aknoun, 16300 Algiers, Algeria
    Joint Bone Spine 77:70-2. 2010
  2. doi request reprint Juvenile hyaline fibromatosis: focus on radiographic features in adulthood
    Samy Slimani
    Department of Rheumatology, Ben Aknoun Hospital, Algiers, 16300, Algeria
    Rheumatol Int 31:273-6. 2011
  3. doi request reprint Rituximab in rheumatoid arthritis and the risk of malignancies: report from a French cohort
    Samy Slimani
    Department of Immuno Rheumatology, Lapeyronie Teaching Hospital, 34295 Montpellier Cedex 5, France
    Joint Bone Spine 78:484-7. 2011

Collaborators

Detail Information

Publications3

  1. doi request reprint Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate
    Samy Slimani
    Department of Rheumatology, Ben Aknoun Hospital, rue des Deux Bassins, Ben Aknoun, 16300 Algiers, Algeria
    Joint Bone Spine 77:70-2. 2010
    ..Pamidronate (2mg/kg/year) produced dramatic improvement of pain and function within 2 months and calcinosis had completely resolved by 2 years. No new calcifications have been noted with a 5-year follow-up...
  2. doi request reprint Juvenile hyaline fibromatosis: focus on radiographic features in adulthood
    Samy Slimani
    Department of Rheumatology, Ben Aknoun Hospital, Algiers, 16300, Algeria
    Rheumatol Int 31:273-6. 2011
    ..The main purpose of this report is to increase the information available related to the radiographic manifestations and prognosis of JHF...
  3. doi request reprint Rituximab in rheumatoid arthritis and the risk of malignancies: report from a French cohort
    Samy Slimani
    Department of Immuno Rheumatology, Lapeyronie Teaching Hospital, 34295 Montpellier Cedex 5, France
    Joint Bone Spine 78:484-7. 2011
    ..To determine in real-life conditions the safety of treatment with rituximab (RTX) in patients with rheumatoid arthritis (RA) regarding malignancies...